- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02778633
Mean Systemic Filling Pressure and Heart Performance Predicting Fluid Responsiveness in Sepsis
January 23, 2018 updated by: L.P.B. Meijs, Catharina Ziekenhuis Eindhoven
Mean Systemic Filling Pressure and Heart Performance as Predictors of Successful Fluid Responsiveness in Patients With Sepsis
The purpose of this study is to determine fluid responsiveness in critically ill patients by measuring mean systemic filling pressure on the intensive care unit.
Study Overview
Status
Unknown
Conditions
Detailed Description
The assessment of the cardiovascular state in critically ill patients is subject to difficulties in terms of the fact that several hemodynamic parameters, for example mean arterial blood pressure (MAP) and cardiac output (CO) supply insufficient information about the circulating volume and cardiac performance.
There is a clinical need to adequate determination of intravascular volume status and therefore reliable predictors of fluid responsiveness are highly relevant.
However, in determining the fluid status of a patient, the lack of appreciation of the venous side of the circulation persists today, which is greatly due to the inability to appropriately assess the venous side of the circulation.
The importance of the venous part of the circulation is moreover reflected by the fact that an increase in venous resistance does reduce CO many times more than a similar increase in arterial resistance.
Mean systemic filling pressure (Pms), which is defined as the pressure equal to the pressure which would be measured if the heart should suddenly stop pumping and all (arterial and venous) the pressures in the entire circulatory system should be brought to equilibrium instantaneously, is a good, complete and reliable reflection of the total intravascular fluid compartment.
Passive leg raising (PLR) represents a "self-volume challenge" that predicts preload responsiveness and the transient hemodynamic changes on venous return can be directly monitored in ventilated patients, provided that there is an intact circulation, in order to test the amount of volume responsiveness.
Study Type
Observational
Enrollment (Anticipated)
20
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: LPB Meijs, MD
- Phone Number: 00312399111
- Email: Loek.Meijs@catharinaziekenhuis.nl
Study Contact Backup
- Name: LPB Meijs, MD
- Phone Number: 0031-40-2399111
- Email: Loek.Meijs@catharinaziekenhuis.nl
Study Locations
-
-
North Brabant
-
Eindhoven, North Brabant, Netherlands, 5623 EJ
- Recruiting
- Catharina Hospital
-
Contact:
- L.P.B. Meijs, MD
- Phone Number: 0031-40-2399111
- Email: loek.meijs@catharinaziekenhuis.nl
-
Contact:
- A.J.G.H. Bindels, PhD
- Phone Number: 0031-40-2399111
- Email: Alex.Bindels@catharinaziekenhuis.nl
-
Principal Investigator:
- Loek Meijs, MD
-
Principal Investigator:
- A.J.G.H. Bindels, PhD
-
Sub-Investigator:
- A. Roos, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 120 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Septic patients on ICU
Description
Inclusion Criteria:
- Patients must be older than 18 years, and must be equipped with a pulse-contour cardiac output system with a central venous catheter.
- Patients will be subsequently connected to the hemodynamic monitoring device Navigator™.
- In those patients with clinical signs of inadequate tissue perfusion, passive leg raising and standardized fluid challenge will be performed.
Exclusion Criteria:
- Patients with assist devices (e.g. intra aortic balloon pump, Impella®, ECMO), patients with arrhythmias (either atrial of ventricular) will be excluded from the study.
- Also, patients with inguinal impairment or contraindications for a passive leg raising will be excluded (such as deep venous thrombosis or elastic compression stocking), head trauma, an increase intra-abdominal pressure suspected by clinical context and examination as well as patients with absolute contraindications for fluid challenge.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
---|
Sepsis
Patients diagnosed with septic shock, admitted to the intensive care unit, with a good left ventricular ejection fraction without significant co-morbidity are highly eligible for this study.
Patients must be equipped with a pulse-contour cardiac output (PICCO)-system with a central venous catheter which will be applied by the intensivist on admission.Patients will be subsequently connected to the hemodynamic monitoring device Navigator™.
In those patients with clinical signs of inadequate tissue perfusion, passive leg raising and standardized fluid challenge will be performed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean systemic filling pressure (Pms)
Time Frame: 1 hour
|
An increase in mean systemic filling pressure after (self)volume-challenge indicating volume responsiveness of the patient
|
1 hour
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Heart performance (eH)
Time Frame: 1 hour
|
Quotient of driving pressure of venous return in mmHg
|
1 hour
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Secondary hemodynamic parameters
Time Frame: 1 hour
|
Heart Rate
|
1 hour
|
Secondary hemodynamic parameters
Time Frame: 1 hour
|
Mean Arterial Blood Pressure
|
1 hour
|
Secondary hemodynamic parameters
Time Frame: 1 hour
|
Cardiac Index
|
1 hour
|
Secondary hemodynamic parameters
Time Frame: 1 hour
|
Central Venous Pressure
|
1 hour
|
Secondary hemodynamic parameters
Time Frame: 1 hour
|
Systemic Vascular Resistance
|
1 hour
|
Secondary hemodynamic parameters
Time Frame: 1 hour
|
Pulse Pressure Variation
|
1 hour
|
Secondary hemodynamic parameters
Time Frame: 1 hour
|
Pulmonary Vascular Permeability Index
|
1 hour
|
Secondary hemodynamic parameters
Time Frame: 1 hour
|
Plethysmographic Oxygen Saturation
|
1 hour
|
Secondary hemodynamic parameters
Time Frame: 1 hour
|
Delivery of Oxygen Index
|
1 hour
|
Secondary hemodynamic parameters
Time Frame: 1 hour
|
Mechanical Ventilation Settings
|
1 hour
|
Secondary hemodynamic parameters
Time Frame: 1 hour
|
End-tidal CO2
|
1 hour
|
Secondary hemodynamic parameters
Time Frame: 1 hour
|
Peripheral Temperature
|
1 hour
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2013
Primary Completion (Anticipated)
May 1, 2019
Study Completion (Anticipated)
December 1, 2019
Study Registration Dates
First Submitted
May 18, 2016
First Submitted That Met QC Criteria
May 19, 2016
First Posted (Estimate)
May 20, 2016
Study Record Updates
Last Update Posted (Actual)
January 25, 2018
Last Update Submitted That Met QC Criteria
January 23, 2018
Last Verified
January 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- M12-1272
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
IPD Plan Description
No, data remain anonymized within hospital and property of PI.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiac Output, High
-
HeartBeat Technologies LTDUnknownLow Cardiac Output | High Cardiac OutputIsrael
-
Karolinska InstitutetRecruitingCardiac Output, Low | Cardiac Output, HighSweden
-
Cairo UniversityCompletedCardiac Output, Low | Cardiac Output, HighEgypt
-
Karolinska InstitutetRegion StockholmCompletedCardiac Output, Low | Cardiac Output, HighSweden
-
The Royal Wolverhampton Hospitals NHS TrustWithdrawnCardiac Output, Low | Cardiac Output, High
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Philips HealthcareCompletedCardiac Output, Low | Cardiac Output, HighNetherlands
-
Edwards LifesciencesCompletedCardiac Output, Low | Cardiac Output, HighSwitzerland, Finland
-
Medical University of ViennaMedical University of GrazRecruitingPerfusion; Complications | Cardiac Output, Low | Cardiac Output, HighAustria
-
University Hospital Inselspital, BerneEdwards LifesciencesCompletedVasodilation | Vasoconstriction | Hemodynamics | Cardiac Output, Low | Cardiac Output, HighSwitzerland
-
Montreal Heart InstituteCompletedHypovolemia | Cardiac Output, Low | Cardiac Output, HighCanada